Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model

• Candidate PET imaging biomarkers Pde10a, mHTT and D 1 R are responsive to early m Htt lowering. • Candidate CSF biomarkers Snc4b and Ace are responsive to early m Htt lowering. • Early intervention with moderate (∼50 %) whole-body m Htt lowering is required to delay progression of phenotypes; late intervention resulted in minimal benefits.

Authors

Institutions

Publication Details

Journal
Neurobiology of Disease
Published
2025-04-09
DOI
https://doi.org/10.1016/j.nbd.2025.106906
Citations
3
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
2.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model

Jim Rosinski, Longbin Liu, Alan Miranda, Joachim Fentz et al.
3 citations
Neurobiology of Disease
Genetic Neurodegenerative Diseases
2.73
article

Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model

Jim Rosinski, Longbin Liu, Alan Miranda, Joachim Fentz, Marleen Verhoye, Jeroen Verhaeghe, Liesbeth Everix, Ignacio Muñoz-Sanjuán, Tim Fieblinger, Jonathan Bard, Jannis Gundelach, Daniele Bertoglio, Mari J. Aaltonen, John C. Obenauer, Franziska Zajicek, Thomas Wild, Deanna M. Marchionini, Stef De Lombaerde, Steven Staelens, Jonathan Greene, Joëlle van Rijswijk, Carleen M Kluger, Aglaia Kakoulidou
article en
3 citations

Abstract

• Candidate PET imaging biomarkers Pde10a, mHTT and D 1 R are responsive to early m Htt lowering. • Candidate CSF biomarkers Snc4b and Ace are responsive to early m Htt lowering. • Early intervention with moderate (∼50 %) whole-body m Htt lowering is required to delay progression of phenotypes; late intervention resulted in minimal benefits.

Neurobiology of DiseaseVol. 209
University of Antwerp (BE), CHDI Foundation (US), Rancho BioSciences (United States) (US), Evotec (United States) (US)
CHDI Foundation
Zero hunger
Openalex Percentile: Top 11%
Genetic Neurodegenerative Diseases
2.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.